hyperpigmentation of t...Figure 16.29 (a) Cutaneous cGVHD characterized by diffuse dermal and subcuta...Figure 16.30 Cutaneous cGVHD characterized by band‐like deep dermal sclerosi...Figure 16.31 Cutaneous cGVHD characterized by diffuse dermal fibrosis and th...Figure 16.32 A case of overlap skin GVHD rapidly arose 12 months after allog...Figure 16.33 A case of GVHD overlap in which a morbilliform rash typically o...Figure 16.34 The high‐frequency US study of the skin has proved useful in id...8 Chapter 17Figure 17.1 Characteristics of lens structures and different types of catara...
9 Chapter 18Figure 18.1 Oral cGVHD.Figure 18.2 SCC of the oral mucosa in a patient with long‐lasting cGVHD invo...
10 Chapter 20Figure 20.1 Reproductive Health considerations throughout HSCT. apost‐pubert...
11 Chapter 21Figure 21.1 Reproductive Health considerations throughout HSCT.Figure 21.2 Form for assessment of genital cGVHD.Figure 21.3 Female external genitalia anatomy.
12 Chapter 22Figure 22.1 Predicting age of ovarian failure after radiation.Figure 22.2 Risk of azoospermia according to score. TBI counted for 2 points...Figure 22.3 Fertility preservation measures and counseling in HSCT. The grap...
13 Chapter 24Figure 24.1 Spectrum of pulmonary complications following HSCT.Figure 24.2 High‐resolution chest CT image of a patient with bronchiolitis o...Figure 24.3 Chest CT scan image in a patient with pulmonary fibrosis and air...Figure 24.4 Algorithm of the initial diagnostic approach to HSCT patient pre...
14 Chapter 25Figure 25.1 Cumulative incidence of congestive heart failure after HSCT for ...Figure 25.2 Possible multifactorial mechanisms for accelerated development o...
15 Chapter 27Figure 27.1 Image from upper endoscopy of a 27‐year‐old man with aplastic an...Figure 27.2 Image from flexible sigmoidoscopy of a 36‐year‐old man with acut...Figure 27.3 Image from flexible sigmoidoscopy of a 30‐year‐old woman with no...Figure 27.4 Image from flexible sigmoidoscopy of a 42‐year‐old woman with B‐...
16 Chapter 29Figure 29.1 Clinical spectrum of renal complications.
17 Chapter 31Figure 31.1 Chronologic appearance of neurologic complications of HSCT recip...Figure 31.2 Late‐onset neurologic complications of hematopoietic stem cell t...
18 Chapter 32Figure 32.1 Neurocognitive domains, selected aspects of cognitive functionin...
19 Chapter 34Figure 34.1 Factors contributing to the development and persistence of fatig...
20 Chapter 35Figure 35.1 Conceptual Model of Various Social and Psychological Issues.
21 Chapter 36Figure 36.1 Revised Wilson and Cleary Conceptual Model of Quality‐of‐Life Mo...
22 Chapter 41Figure 41.1 The different types of CAM and examples of different types as pe...Figure 41.2 EDUCATE framework to approach CAM discussions.
23 Chapter 42Figure 42.1 The five dimensions of adherence as suggested by the World Healt...
24 Chapter 44Figure 44.1 Conceptual framework of the Comprehensive health status Model. S...Figure 44.2 Typical pattern of recovery after hematopoietic stem‐cell transp...
25 Appendix 2Figure A2.1 Typical screen of the eGVHD App.Figure A2.2 QR codes for download of the eGVHD App.Figure A2.3 International uptake of the eGVHD App based on App Store informa...
Guide
4 Foreword to the Second Edition
5 Foreword (from first edition)
9 APPENDIX 1 Commonly used transplant‐related medications in long‐term survivors
11 Index
12 WILEY END USER LICENSE AGREEMENT
Pages
1 iii
2 iv
3 vii
4 viii
5 ix
6 x
7 xi
8 xii
9 1
10 3
11 4
12 5
13 6
14 7
15 8
16
